Zhang Lab

National University of Singapore

Home Research COVID-19 Services Publications People Teaching Job Opening News Forum Lab Only

Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

GLASS

You can:

Go to the GPCR, ligand, or experimental data tables.
Go to the experimental data table for text mining information in PubMed ID column.
Go to the GPCR page and check other ligands which interact with it.
Go to the ligand page and check other GPCRs which it interacts with.
Go back to previous page.

GPCR

Name	5-hydroxytryptamine receptor 1A
Species	Homo sapiens (Human)
Gene	HTR1A
Synonym	5-HT-1A 5-HT1A serotonin receptor 1A 5-HT1A receptor 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled Gpcr18 ADRB2RL1 ADRBRL1 G-21 [ Show all ]
Disease	Urinary incontinence Generalized anxiety disorder Generalized anxiety disorder; Social phobia Hypertension Hypoactive sexual desire disorder Major depressive disorder Major depressive disorder; Episode; Anxiety Migraine Mood disorder Pain Parkinson's disease Premature ejaculation Psychiatric disorder Psychotic disorders Schizoaffective disorder; Schizophrenia Severe mood disorders Unspecified Female sexual dysfunction Eating disorder Schizophrenia Alzheimer disease Alzheimer disease; Peripheral sensory neuropathies; Lateral sclerosis Bulimia nervosa; Severe mood disorders Cervical dystonia; Spasm Cognitive disorders Anxiety disorder Depression Coronary artery disease [ Show all ]
Length	422
Amino acid sequence	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ
UniProt	P08908
Protein Data Bank	N/A
GPCR-HGmod model	P08908
3D structure model	This predicted structure model is from GPCR-EXP P08908.
BioLiP	N/A
Therapeutic Target Database	T78709
ChEMBL	CHEMBL214
IUPHAR	1
DrugBank	BE0000291

Ligand

Name	Bufotenine
Molecular formula	C12H16N2O
IUPAC name	3-[2-(dimethylamino)ethyl]-1H-indol-5-ol
Molecular weight	204.273
Hydrogen bond acceptor	2
Hydrogen bond donor	2
XlogP	1.2
Synonyms	{3-[(2-Dimethylamino)ethyl]-5-indolol} 3-[2-(Dimethylamino)ethyl]-Indol-5-ol 5-OH-DMT CHEMBL416526 Dimethylserotonin FT-0623282 LS-83677 NCGC00247724-01 1H-Indol-5-ol, 3-[2-(dimethylamino)ethyl]- STK368137 3-(2-Dimethylaminoethyl)indol-5-ol 487-93-4 AC1L1UTH C08299 CTK6I0591 DSSTox_CID_28820 INDOL-5-OL, 3-(2-(DIMETHYLAMINO)ETHYL)- Mappine NSC89593 3-(.beta.-Dimethylaminoethyl)-5-hydroxyindole UNII-0A31347TZK 3-[(2-Dimethylamino)ethyl]-5-indolol 3-[2-(Dimethylamino)ethyl]-1H-indol-5-ol # 5-Hydroxy-N, N-dimethyltryptamine BRN 0160628 CHEBI:3210 DB01445 DTXSID0048894 KB-56697 N,N-Dimethyl-5-hydroxytryptamine PDSP2_000007 3-(2-dimethylaminoethyl)-1H-indol-5-ol WLN: T56 BMJ D2N1&1 GQ {3-[(beta-Dimethylamino)ethyl]-5-hydroxyindole} 3-[2-(Dimethylamino)ethyl]indol-5-ol Bufotenine 1.0 mg/ml in Acetonitrile Cinobufotenine DM5-HT GTPL144 Mapine NSC 89593 1H-Indol-5-ol, {3-[2-(dimethylamino)ethyl]-} TC-061237 3-(beta-Dimethylaminoethyl)-5-hydroxyindole 3-[.beta.-(Dimethylamino)ethyl]-5-hydroxyindole 5-22-12-00026 (Beilstein Handbook Reference) AKOS005445162 CAS-487-93-4 D0SP2J DSSTox_GSID_48894 Indol-5-ol, 3-[2-(dimethylamino)ethyl]- N, N-Dimethylserotonin 0A31347TZK Oprea1_475603 3-(2-(Dimethylamino)ethyl)-1H-indol-5-ol VTTONGPRPXSUTJ-UHFFFAOYSA-N 3-[2-(Dimethylamino)ethyl]-5-indolol 5-Hydroxy-N,N-dimethyltryptamine Bufotenin DEA No. 7433 EINECS 207-667-9 L001128 N,N-Dimethylserotonin 1H-Indol-5-ol, 3-(2-(dimethylamino)ethyl)- SCHEMBL518028 3-(2-Dimethylaminoethyl)-5-indolol ZINC1070 3-[beta-(Dimethylamino)ethyl]-5-hydroxyindole 8-methoxy-2,2,5,6-tetramethyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one Bufotenine solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material Cohoba DMT,5-OH InChI=1/C12H16N2O/c1-14(2)6-5-9-8-13-12-4-3-10(15)7-11(9)12/h3-4,7-8,13,15H,5-6H2,1-2H Mappin NSC-89593 1H-Indol-5-ol,3-[2-(dimethylamino)ethyl]- Tox21_112890 3-[(.beta.-Dimethylamino)ethyl]-5-hydroxyindole 3-[2-(Dimethylamino)ethyl]-1H-indol-5-ol 5-hydroxy-dimethyltryptamine BDBM50024206 cebilcin DB-012579 DSSTox_RID_83089 Indol-5-ol, {3-[2-(dimethylamino)ethyl]-} N,N-Dimethyl-5-HT 1,5-benzoxazepin-4(5H)-one, 2,3-dihydro-8-methoxy-2,2,5,6-tetramethyl- PDSP1_000007 3-(2-(Dimethylamino)ethyl)-1H-indol-5-ol (ACD/Name 4.0) VZ36427 [ Show all ]
Inchi Key	VTTONGPRPXSUTJ-UHFFFAOYSA-N
Inchi ID	InChI=1S/C12H16N2O/c1-14(2)6-5-9-8-13-12-4-3-10(15)7-11(9)12/h3-4,7-8,13,15H,5-6H2,1-2H3
PubChem CID	10257
ChEMBL	CHEMBL416526
IUPHAR	144
BindingDB	50024206
DrugBank	N/A
Structure SDF download
Lipinski's druglikeness	This ligand satisfies Lipinski's rule of five.

Experimental Data

Parameter	Value	Reference	Database source
Kd	3.162 nM	PMID19754201	ChEMBL

zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417